JPRN-UMIN000004026CompletedPhase 2
A quantification of circulating tumor cells in patients with gastric cancer by telomerase-specific oncolytic adenoviral agents - A quantification of circulating tumor cells in gastric cancer patients by telomerase-specific oncolytic adenoviral agents
Digestive Disease Center, Showa University Nothern Yokohama Hospital0 sites200 target enrollmentStarted: August 10, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1)Synchronous or metachronous malignancy. 2)Pregnant women. 3)Breast-feeding women. 4)Active or chronic viral hepatitis. 5)Active bacterial or fungous infection. 6)Diabetes mellitus. 7)Systemic administration of corticosteroids. 8)Unstable hypertension.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
ogistics of Circulating Tumor Cells in Peripheral Blood Collection in Patients with Metastatic Prostate Cancermetastatic prostate cancergemetastaseerd prostaatkanker10027476NL-OMON40759eids Universitair Medisch Centrum10
Withdrawn
Not Applicable
Effectiveness of monitoring levels of Circulating Tumour Cells (CTCs) in blood for early detection and treatment monitoring in cancer patients.CancerACTRN12617001496303Survon Pte Ltd300
Active, not recruiting
Not Applicable
Can cancer cells be found and counted in blood samples from patients with bone sarcoma?Specialty: Cancer, Primary sub-specialty: SarcomaUKCRC code/ Disease: Cancer/ Malignant neoplasms of bone and articular cartilageSarcomaCancerISRCTN29619083The Newcastle Upon Tyne Hospitals NHS Foundation Trust30
Recruiting
Not Applicable
Characterization of circulating tumour cells undergoing epithelial-mesenchymal transition in hepatocellular carcinoma and its revlevance in tumor staging modalitiesCirculating tumor cells, Hepatocellular carcinoma, Epithelial-mesenchymal transition, Phenotype, prognosisHepatocellular carcinomaTCTR20220613008Faculty of Medicine, Chiang Mai University44
Recruiting
Not Applicable
The detection of cells originating from thyroid nodules in bloodstreamNeoplasmsKCT0008179Seoul National University Bundang Hospital300